This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| International Society of Radiopharmaceutical Sciences | |
|---|---|
| Name | International Society of Radiopharmaceutical Sciences |
| Type | Professional society |
| Founded | 1999 |
| Headquarters | Geneva |
| Region served | International |
| Leader title | President |
International Society of Radiopharmaceutical Sciences is a professional association dedicated to the advancement of radiopharmaceutical science, nuclear medicine, and molecular imaging. The society connects researchers, clinicians, and industry professionals from institutions such as European Organization for Nuclear Research, National Institutes of Health, Massachusetts Institute of Technology, University of Oxford, and University of Tokyo, fostering collaboration across continents including United States, United Kingdom, Germany, Japan, and Australia.
The society emerged in the late 20th century amid growth in radiopharmacy at centers like Brookhaven National Laboratory, Lawrence Berkeley National Laboratory, and Paul Scherrer Institute, following landmark developments associated with Marie Curie, Ernest Lawrence, Otto Hahn, and Wilhelm Conrad Röntgen. Early meetings paralleled conferences hosted by Society of Nuclear Medicine and Molecular Imaging, European Association of Nuclear Medicine, and International Atomic Energy Agency, and attracted delegations from Harvard Medical School, Johns Hopkins University, Karolinska Institutet, and McGill University. Founding influences included programs at Uppsala University, University of Vienna, Friedrich Miescher Institute, and initiatives linked to World Health Organization technical cooperation. Over the 2000s the society expanded alongside projects at CERN, Riken, Kobe University, and Seoul National University.
The society aims to promote research, education, and clinical translation in radiopharmaceutical sciences, aligning with priorities of entities such as National Cancer Institute, European Commission, Wellcome Trust, and Howard Hughes Medical Institute. Objectives include facilitating training programs modeled on curricula from Imperial College London, Stanford University, University of California, San Francisco, and Tokyo Institute of Technology; supporting regulatory dialogue involving Food and Drug Administration, European Medicines Agency, and Pharmaceuticals and Medical Devices Agency; and advancing standards compatible with guidance from International Atomic Energy Agency and International Organization for Standardization.
Governance mirrors structures used by Royal Society, American Academy of Arts and Sciences, and Royal College of Radiologists, with an elected executive composed of officers and councilors drawn from institutions like Mayo Clinic, Cleveland Clinic, Karolinska University Hospital, Guy’s and St Thomas’ NHS Foundation Trust, and Tokyo Medical University. Committees cover scientific program planning, education, regulatory affairs, and finance, incorporating experts affiliated with European Molecular Biology Laboratory, Max Planck Society, Chinese Academy of Sciences, and Australian National University. Advisory boards have included members linked to Nobel Prize laureates and leaders from Royal Society of Chemistry, American Chemical Society, and Institute of Physics.
The society organizes biennial congresses and satellite symposia often co-located with events hosted by European Association of Nuclear Medicine, Society of Nuclear Medicine and Molecular Imaging, Radiological Society of North America, and World Molecular Imaging Congress. Venues have included cities such as Geneva, Vienna, London, Boston, Tokyo, Seoul, Sydney, and Zurich, attracting speakers from Cambridge University, Princeton University, ETH Zürich, University of Toronto, and Peking University. Program tracks parallel themes from major projects like Human Genome Project, Human Cell Atlas, and collaborations with research infrastructures such as EMBL and ELIXIR.
The society disseminates research through proceedings, position statements, and educational materials, often published in journals comparable to Journal of Nuclear Medicine, European Journal of Nuclear Medicine and Molecular Imaging, Nature Medicine, Science Translational Medicine, and The Lancet Oncology. It curates protocols and best practices influenced by work at Salk Institute, Cold Spring Harbor Laboratory, Broad Institute, and Scripps Research, and maintains online resources for radiochemistry, radiopharmacy, and radiobiology training that echo repositories from PubMed Central, arXiv, bioRxiv, and ClinicalTrials.gov.
The society partners with governmental and non-governmental organizations including International Atomic Energy Agency, World Health Organization, European Commission, National Institutes of Health, and major academic consortia such as Consortium of European Paediatric Research, Global Alliance for Genomics and Health, and Cancer Research UK. Industry collaborations span multinational corporations and startups associated with GE Healthcare, Siemens Healthineers, Philips Healthcare, Novartis, Bayer, Roche, Pfizer, and specialist manufacturers at sites like PerkinElmer and Bruker. Collaborative research projects have interfaced with initiatives at CERN, Riken, J-PARC, and ITER for isotope production and technology transfer.
The society confers awards recognizing excellence in radiopharmaceutical chemistry, translational research, and lifetime achievement, paralleling honors such as the Nobel Prize in Chemistry, Lasker Award, King Faisal International Prize, and Royal Society of Chemistry awards. Laureates have originated from institutions like University College London, Yale University, Duke University, University of Pennsylvania, and Monash University, and recipients frequently hold fellowships with bodies such as Wellcome Trust, European Research Council, Howard Hughes Medical Institute, and national academies including the National Academy of Sciences and Royal Society.
Category:Scientific societies Category:Nuclear medicine Category:Radiopharmacy